Q32 Bio (QTTB) Operating Income Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | 36.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.85% |
| Dec 31, 2025 | 415.84% |
| Sep 30, 2025 | 59.73% |
| Jun 30, 2025 | 48.82% |
| Mar 31, 2025 | 17.62% |
| Dec 31, 2024 | 43.72% |
| Sep 30, 2024 | -141.27% |
| Jun 30, 2024 | -146.31% |
| Mar 31, 2024 | -101.32% |
| Dec 31, 2023 | -126.37% |
| Sep 30, 2023 | 76.27% |
| Jun 30, 2023 | 74.30% |
| Mar 31, 2023 | 80.40% |
| Dec 31, 2022 | 131.89% |
| Sep 30, 2022 | -7.18% |
| Jun 30, 2022 | 7.35% |
| Mar 31, 2022 | -3,285.96% |
| Dec 31, 2021 | 241.64% |
| Sep 30, 2021 | -8.45% |
| Jun 30, 2021 | 14.41% |
| Mar 31, 2021 | 96.96% |
| Dec 31, 2020 | -16.60% |
| Sep 30, 2020 | 9.64% |
| Jun 30, 2020 | -27.61% |
| Mar 31, 2020 | -45.25% |
| Dec 31, 2019 | -26.71% |
| Sep 30, 2019 | -100.12% |
| Jun 30, 2019 | -108.41% |
| Mar 31, 2019 | -134.88% |
| Dec 31, 2018 | -64.51% |
| Sep 30, 2018 | -134.59% |
| Jun 30, 2018 | -122.27% |
| Mar 31, 2018 | -127.99% |